MRM Health Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
46
- Latest Deal Type
-
Early Stage VC
- Investors
-
7
MRM Health General Information
Description
Developer of drug development platform designed for the development of next-generation optimized consortium therapeutics based on the human microbiome. The company has built a diversified pipeline with its proprietary collaborative trial in relapsed aggressive lymphoma platform to design, optimize, and manufacture bacterial consortia as single drug substances, enabling life science researchers to overcome the critical bottlenecks related to engraftment, and efficacy hampering microbiome-based product development.
Contact Information
Website
www.mrmhealth.comCorporate Office
- Technologiepark 73
- 9052 Ghent
- Belgium
Corporate Office
- Technologiepark 73
- 9052 Ghent
- Belgium
MRM Health Timeline
MRM Health Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC | 02-Feb-2023 | Completed | Clinical Trials - Phase 2 | |||
| 2. Early Stage VC | 02-Mar-2022 | Completed | Clinical Trials - Phase 2 | |||
| 1. Early Stage VC (Series A) | 19-Feb-2020 | $15.6M | $15.4M | Completed | Clinical Trials - Phase 2 |
MRM Health Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preference Class A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
MRM Health Patents
MRM Health Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2022426633-A1 | Microbial communities | Pending | 27-Dec-2021 | ||
| EP-4456905-A1 | Microbial communities | Pending | 27-Dec-2021 |
MRM Health Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
MRM Health Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Korys Investments | Family Office | Minority | ||
| Ackermans & van Haaren | Growth/Expansion | Minority | ||
| DuPont Nutrition & Health | Corporation | Minority | ||
| Mérieux Equity Partners | PE/Buyout | Minority | ||
| MRM Technologies | VC-Backed Company | Minority |
MRM Health FAQs
-
When was MRM Health founded?
MRM Health was founded in 2020.
-
Where is MRM Health headquartered?
MRM Health is headquartered in Ghent, Belgium.
-
What is the size of MRM Health?
MRM Health has 46 total employees.
-
What industry is MRM Health in?
MRM Health’s primary industry is Drug Discovery.
-
Is MRM Health a private or public company?
MRM Health is a Private company.
-
What is MRM Health’s current revenue?
The current revenue for MRM Health is .
-
How much funding has MRM Health raised over time?
MRM Health has raised $24.6M.
-
Who are MRM Health’s investors?
Korys Investments, Ackermans & van Haaren, DuPont Nutrition & Health, Mérieux Equity Partners, and MRM Technologies are 5 of 7 investors who have invested in MRM Health.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
